BCDA - BioCardia stock jumps premarket as FDA approves heart failure trial
2023-11-14 07:53:50 ET
More on BioCardia
- BioCardia, Inc. (BCDA) Q3 2023 Earnings Call Transcript
- BioCardia doesn't see Phase 3 study meeting primary endpoint, stock slides
- Seeking Alpha’s Quant Rating on BioCardia
- Historical earnings data for BioCardia
- Financial information for BioCardia
For further details see:
BioCardia stock jumps premarket as FDA approves heart failure trial